(VYNE) - Analyst Comments

(VYNE) – Analyst Comments

May 18, 2022 06:08 AM H.C. Wainwright Reiterates Buy Rating, $7 Price Target on VYNE Therapeutics (VYNE)
May 13, 2022 06:27 AM Cantor Fitzgerald Reiterates VYNE Therapeutics (VYNE) at Overweight with $10 Price Target, Expects "Upwards Earnings Estimate Revisions and Multiple Expansion"
Apr 7, 2022 09:08 AM
Mar 17, 2022 10:55 AM
Mar 7, 2022 07:36 AM
Jan 13, 2022 08:12 AM
Dec 28, 2021 05:55 AM
Nov 10, 2021 01:31 PM
Aug 12, 2021 12:19 PM
Oct 29, 2020 07:15 AM
Oct 28, 2020 06:53 AM